March 8, 2015 Critical Path Institute Launches New Consortium Dedicated To Duchenne Muscular Dystrophy August 3, 2015 Critical Path Institute Launches New Consortium Dedicated To Duchenne Muscular Dystrophy Tucson, Arizona – August
CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia July 23, 2015 CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia Austin, TX – 23 Ju
Critical Path Institute Establishes The Global Pediatric Clinical Trials Network Pre-Launch Consortium July 22, 2015 Critical Path Institute Establishes The Global Pediatric Clinical Trials Network Pre-Launch Con
Critical Path Institute Announces Appointments of Peter Hutt, Alan Levin, and Paula Olsiewski To Its Board of Directors June 25, 2015 Critical Path Institute Announces Appointments of Peter Hutt, Alan Levin, and Paula Olsiewski To Its Board of Direc
January 6, 2015 Critical Path Institute Secures Regulatory Support For Autosomal Dominant Polycystic Kidney Disease (ADPKD) Biomarker June 1, 2015 Critical Path Institute Secures Regulatory Support For Autosomal Dominant Polycystic Kidney Disease (ADPKD) Biomarke
Critical Path Institute Launches New Neonatal Consortium May 19, 2015 Critical Path Institute Launches New Neonatal Consortium The International Neonatal Consortium (INC) aims to accelera
C-Path Selected as Host For New TB Clinical Trial Data-Sharing Platform May 4, 2015 Host For New TB Clinical Trial Data-Sharing Platform Selected TUCSON, Ariz., May 4, 2015 — The non-profit Critical P
Critical Path Institute Secures Regulatory Support For Parkinson’s And Alzheimer’s Disease Biomarkers April 27, 2015 Critical Path Institute Secures Regulatory Support For Parkinson’s And Alzheimer’s Disease Biomarkers F
Critical Path Institute Secures Regulatory Support For Skeletal Muscle Safety Biomarkers April 13, 2015 Critical Path Institute Secures Regulatory Support For Skeletal Muscle Safety Biomarkers FDA and EMA Letters of Sup
European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development February 6, 2015 European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development Provides maj
